The landscape of dementia diagnosis has evolved drastically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades right before signs or symptoms arise. Although these technological developments represent extraordinary development in knowing neurodegenerative health conditions... https://erwinp530dny7.madmouseblog.com/profile